Genzyme Sells Genetic Testing Unit to LabCorp for $925 Million
Genzyme (GENZ) announced that it has agreed to sell Genzyme Genetics to Laboratory Corporation of America Holdings (LabCorp) (LH) for for $925 million in cash.
Cambridge, Mass.-based Genzyme said that under the terms of the agreement, LabCorp will pur…